Literature DB >> 20004111

Low-dose erythropoietin aggravates endotoxin-induced organ damage in conscious rats.

Wen-Tien Wu1, Tsung-Ming Hu, Nien-Tsung Lin, Yi-Maun Subeq, Ru-Ping Lee, Bang-Gee Hsu.   

Abstract

Endotoxin shock can induce the production of several inflammatory mediators such as TNF-alpha, IL-6, and IL-1beta, leading to multiple organ dysfunction and death. Erythropoietin (EPO) has been found to interact with its receptor (EPO-R), expressed in a wide variety of non-hematopoietic tissues, to induce a range of pleiotropic cytoprotective actions. We investigated the effects of low doses of EPO (300U/kg, intravenous administration) on the physiopathology and cytokine levels in endotoxin shock in conscious rats. Endotoxin shock was induced by intravenous injection of Escherichia coli lipopolysaccharide (20mg/kg) in conscious rats. Mean arterial pressure (MAP) and heart rate (HR) were continuously monitored for 48h after LPS administration. Levels of biochemical and cytokine parameters, including glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), blood urea nitrogen (BUN), creatinine (Cre), lactic dehydrogenase (LDH), and creatine phosphokinase (CPK) were measured at 0, 1, 3, 6, 9, 12, 18, 24, and 48h after sepsis. Serum TNF-alpha, IL-6, and IL-1beta level was measured at 1h after sepsis. Endotoxin shock significantly increased blood GOT, GPT, BUN, Cre, LDH, CPK, TNF-alpha, IL-6, IL-1beta levels, and HR, while it decreased MAP. EPO further increased the markers of organ injury (GOT, GPT, BUN, Cre, LDH, and CPK), inflammatory biomarkers (TNF-alpha, IL-6, and IL-1beta) and did not affect MAP and HR after LPS. EPO disserved endotoxin shock-induced liver, kidney, lung, and small intestine damage in conscious rats. In conclusion, pre-treatment with low doses of EPO increased the release of TNF-alpha, IL-6, and IL-1beta, along with aggravating endotoxin shock-induced markers of organ injury in conscious rats. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004111     DOI: 10.1016/j.cyto.2009.11.002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

Review 1.  Erythropoetin as a novel agent with pleiotropic effects against acute lung injury.

Authors:  Sotirios Kakavas; Theano Demestiha; Panagiotis Vasileiou; Theodoros Xanthos
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

2.  Differential short-term regional effects of early high dose erythropoietin on white matter in preterm lambs after mechanical ventilation.

Authors:  Samantha K Barton; Annie R A McDougall; Jacqueline M Melville; Timothy J M Moss; Valerie A Zahra; Tammy Lim; Kelly J Crossley; Graeme R Polglase; Mary Tolcos
Journal:  J Physiol       Date:  2015-10-08       Impact factor: 5.182

3.  Prophylactic erythropoietin exacerbates ventilation-induced lung inflammation and injury in preterm lambs.

Authors:  Graeme R Polglase; Samantha K Barton; Jacqueline M Melville; Valerie Zahra; Megan J Wallace; Melissa L Siew; Mary Tolcos; Timothy J M Moss
Journal:  J Physiol       Date:  2014-03-03       Impact factor: 5.182

4.  Erythropoietin and organ protection: lessons from negative clinical trials.

Authors:  Ronald G Pearl
Journal:  Crit Care       Date:  2014-09-11       Impact factor: 9.097

Review 5.  Neuroplasticity and the next wave of antidepressant strategies.

Authors:  Shawn Hayley; Darcy Litteljohn
Journal:  Front Cell Neurosci       Date:  2013-11-20       Impact factor: 5.505

6.  Effect of erythropoietin on primed leucocyte expression profile.

Authors:  Mirko Pesce; Paolo Felaco; Sara Franceschelli; Lorenza Speranza; Alfredo Grilli; Maria Anna De Lutiis; Alessio Ferrone; Vittorio Sirolli; Mario Bonomini; Mario Felaco; Antonia Patruno
Journal:  Open Biol       Date:  2014-06       Impact factor: 6.411

Review 7.  Is There a Role for Hematopoietic Growth Factors During Sepsis?

Authors:  Benjamin G Chousterman; Marine Arnaud
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 7.561

8.  Protective role of recombinant human erythropoietin in kidney and lung injury following renal bilateral ischemia-reperfusion in rat model.

Authors:  Maryam Moeini; Mehdi Nematbakhsh; Mohammad Fazilati; Ardeshir Talebi; Ali Asghar Pilehvarian; Fariba Azarkish; Fatemeh Eshraghi-Jazi; Zahra Pezeshki
Journal:  Int J Prev Med       Date:  2013-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.